These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25384711)

  • 1. Risk management for moisture related effects in dry manufacturing processes: a statistical approach.
    Quiroz J; Strong J; Zhang L
    Pharm Dev Technol; 2016 Mar; 21(2):147-51. PubMed ID: 25384711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple Approach to Calculate Random Effects Model Tolerance Intervals to Set Release and Shelf-Life Specification Limits of Pharmaceutical Products.
    Montes RO; Burdick RK; Leblond DJ
    PDA J Pharm Sci Technol; 2019; 73(1):39-59. PubMed ID: 30361286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De-risking pharmaceutical tablet manufacture through process understanding, latent variable modeling, and optimization technologies.
    Muteki K; Swaminathan V; Sekulic SS; Reid GL
    AAPS PharmSciTech; 2011 Dec; 12(4):1324-34. PubMed ID: 21969245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing.
    Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Rome S; Schubert MA; Aerts L; De Beer T
    Eur J Pharm Biopharm; 2018 Jun; 127():92-103. PubMed ID: 29452241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial moisture content in raw material can profoundly influence high shear wet granulation process.
    Shi L; Feng Y; Sun CC
    Int J Pharm; 2011 Sep; 416(1):43-8. PubMed ID: 21718767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of Moisture-Induced Cohesion in Pharmaceutical Mixtures.
    Mukherjee R; Sen K; Fontana L; Mao C; Chaudhuri B
    J Pharm Sci; 2019 Jan; 108(1):223-233. PubMed ID: 30017891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
    Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
    J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic modelling of fluidized bed drying processes of wet porous granules: a review.
    Mortier ST; De Beer T; Gernaey KV; Remon JP; Vervaet C; Nopens I
    Eur J Pharm Biopharm; 2011 Oct; 79(2):205-25. PubMed ID: 21664970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moisture soft sensor for agitated pan dryers using a hybrid modeling approach.
    Wang Z; Kamyar R; Mehdizadeh H; Pendse PY
    Int J Pharm; 2020 Aug; 586():119518. PubMed ID: 32544522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do formulation and process parameters impact blend and unit dose uniformity? Further analysis of the product quality research institute blend uniformity working group industry survey.
    Hancock BC; Garcia-Munoz S
    J Pharm Sci; 2013 Mar; 102(3):982-6. PubMed ID: 23280670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability.
    Hausman DS; Cambron RT; Sakr A
    Int J Pharm; 2005 Aug; 299(1-2):19-33. PubMed ID: 15979262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. System-wide hybrid MPC-PID control of a continuous pharmaceutical tablet manufacturing process via direct compaction.
    Singh R; Ierapetritou M; Ramachandran R
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1164-82. PubMed ID: 23523542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quality by design study applied to an industrial pharmaceutical fluid bed granulation.
    Lourenço V; Lochmann D; Reich G; Menezes JC; Herdling T; Schewitz J
    Eur J Pharm Biopharm; 2012 Jun; 81(2):438-47. PubMed ID: 22446063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multivariate raw material property database to facilitate drug product development and enable in-silico design of pharmaceutical dry powder processes.
    Van Snick B; Dhondt J; Pandelaere K; Bertels J; Mertens R; Klingeleers D; Di Pretoro G; Remon JP; Vervaet C; De Beer T; Vanhoorne V
    Int J Pharm; 2018 Oct; 549(1-2):415-435. PubMed ID: 30118831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A framework for in-silico formulation design using multivariate latent variable regression methods.
    Polizzi MA; García-Muñoz S
    Int J Pharm; 2011 Oct; 418(2):235-42. PubMed ID: 21569826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
    Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-line monitoring of granule moisture in fluidized-bed dryers using microwave resonance technology.
    Buschmüller C; Wiedey W; Döscher C; Dressler J; Breitkreutz J
    Eur J Pharm Biopharm; 2008 May; 69(1):380-7. PubMed ID: 17976965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moisture and drug solid-state monitoring during a continuous drying process using empirical and mass balance models.
    Fonteyne M; Gildemyn D; Peeters E; Mortier ST; Vercruysse J; Gernaey KV; Vervaet C; Remon JP; Nopens I; De Beer T
    Eur J Pharm Biopharm; 2014 Aug; 87(3):616-28. PubMed ID: 24613541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development, validation and transfer of a near infrared method to determine in-line the end point of a fluidised drying process for commercial production batches of an approved oral solid dose pharmaceutical product.
    Peinado A; Hammond J; Scott A
    J Pharm Biomed Anal; 2011 Jan; 54(1):13-20. PubMed ID: 20801599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.